Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation
- Stephen Bent
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Herbal products have gained increasing popularity in the last decade, and are now used by approximately 20% of the population. Herbal products are complex mixtures of organic chemicals that may come from any raw or processed part of a plant, including leaves, stems, flowers, roots, and seeds. Under the current law, herbs are defined as dietary supplements, and manufacturers can therefore produce, sell, and market herbs without first demonstrating safety and efficacy, as is required for pharmaceutical drugs. Although herbs are often perceived as “natural” and therefore safe, many different side effects have been reported owing to active ingredients, contaminants, or interactions with drugs.
Unfortunately, there is limited scientific evidence to establish the safety and efficacy of most herbal products. Of the top 10 herbs, 5 (ginkgo, garlic, St. John’s wort, soy, and kava) have scientific evidence suggesting efficacy, but concerns over safety and a consideration of other medical therapies may temper the decision to use these products.
Herbal products are not likely to become an important alternative to standard medical therapies unless there are changes to the regulation, standardization, and funding for research of these products.
- Barnes, PM, Powell-Griner, E, McFann, K, Nahin, RL (2004) Complementary and alternative medicine use among adults: United States, 2002. Adv Data 343: pp. 1-19
- Swerdlow, JL (2000) Modern Science Embraces Medicinal Plants. Nature’s Medicine: Plants that Heal. National Geographic Society, Washington, DC
- Swerdlow, JL (2000) Medicine Changes: late 19th to early 20th century. Nature’s Medicine: Plants that Heal. National Geographic Society, Washington, D.C.
- Barrett, B, Kiefer, D, Rabago, D (1999) Assessing the risks and benefits of herbal medicine: an overview of scientific evidence. Altern Ther Health Med 5: pp. 40-9
- Rotblatt, M, Ziment, I (2002) Evidence-based herbal medicine. Hanley & Belfus, Philadelphia, PA
- Dubber, MJ, Kanfer, I (2004) High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms. J Pharm Pharm Sci 7: pp. 303-9
- Dietary Supplements: A Framework for Evaluating Safety. National Academies Press, Washington, DC
- Harkey, MR, Henderson, GL, Gershwin, ME, Stern, JS, Hackman, RM (2001) Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 73: pp. 1101-6
- Linde K, Barrett B, Wolkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2006(1):CD000530.
- Turner, RB, Bauer, R, Woelkart, K, Hulsey, TC, Gangemi, JD (2005) An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 353: pp. 341-8 CrossRef
- Blumenthal, M, Farnsworth, NR (2005) Echinacea angustifolia in rhinovirus infections. N Engl J Med 353: pp. 1971-2 CrossRef
- Vogler, BK, Pittler, MH, Ernst, E (1999) The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol 55: pp. 567-75 CrossRef
- Oken, BS, Storzbach, DM, Kaye, JA (1998) The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55: pp. 1409-15 CrossRef
- Solomon, PR, Adams, F, Silver, A, Zimmer, J, DeVeaux, R (2002) Ginkgo for memory enhancement: a randomized controlled trial. JAMA 288: pp. 835-40 CrossRef
- Pittler, MH, Ernst, E (2000) Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 108: pp. 276-81 CrossRef
- Birks J, Grimley EV, Van Dongen M. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2002(4):CD003120.
- Bent, S, Goldberg, H, Padula, A, Avins, AL (2005) Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. J Gen Intern Med 20: pp. 657-61 CrossRef
- Stevinson, C, Pittler, MH, Ernst, E (2000) Garlic for treating hypercholesterolemia; a meta-analysis of randomized clinical trials. Ann Intern Med 133: pp. 420-9
- Koren, MJ (2005) Statin use in a “real-world” clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial. Am J Med 118: pp. 16-21 CrossRef
- Burnham, BE (1995) Garlic as a possible risk for postoperative bleeding. Plast Reconstr Surg 95: pp. 213 CrossRef
- Rose, KD, Croissant, PD, Parliament, CF, Levin, MB (1990) Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 26: pp. 880-2 CrossRef
- Linde K, Mulrow CD, Berner M, Egger M. St John’s wort for depression. Cochrane Database Syst Rev. 2005(2):CD000448.
- Linde, K, Ramirez, G, Mulrow, CD, Pauls, A, Weidenhammer, W, Melchart, D (1996) St John’s wort for depression—an overview and meta-analysis of randomised clinical trials. BMJ 313: pp. 253-8
- Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: a randomized controlled trial. JAMA 287: pp. 1807-14 CrossRef
- Shelton, RC, Keller, MB, Gelenberg, A (2001) Effectiveness of St John’s wort in major depression: a randomized controlled trial. JAMA 285: pp. 1978-86 CrossRef
- Hammerness, P, Basch, E, Ulbricht, C (2003) St John’s wort: a systematic review of adverse effects and drug interactions for the consultation psychiatrist. Psychosomatics 44: pp. 271-82 CrossRef
- Pittler, MH, Ernst, E (1998) Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol 93: pp. 1131-5 CrossRef
- Ernst, E, Pittler, MH (2000) Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth 84: pp. 367-71
- Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev. 2007(4):CD001395.
- Taku, K, Umegaki, K, Sato, Y, Taki, Y, Endoh, K, Watanabe, S (2007) Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 85: pp. 1148-56
- Ulbricht, C, Basch, E (2005) Natural standard herb and supplement reference: evidence-based clinical reviews. Elsevier Mosby, St. Louis, MO
- Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2003(1):CD003383.
- Hepatic toxicity possibly associated with kava-containing products—United States, Germany, and Switzerland, 1999–2002. MMWR Morb Mortal Wkly Rep 51: pp. 1065-7
- Winslow, LC, Kroll, DJ (1998) Herbs as medicines. Arch Intern Med 158: pp. 2192-9 CrossRef
- Ernst, E (1998) Harmless herbs? A review of the recent literature. Am J Med 104: pp. 170-8 CrossRef
- Bent, S, Ko, R (2004) Commonly used herbal medicines in the United States: a review. Am J Med 116: pp. 478-85 CrossRef
- De Smet, PA (2002) Herbal remedies. N Engl J Med 347: pp. 2046-56 CrossRef
- Nortier, JL, Martinez, MC, Schmeiser, HH (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342: pp. 1686-92 CrossRef
- Stickel, F, Patsenker, E, Schuppan, D (2005) Herbal hepatotoxicity. J Hepatol 43: pp. 901-10 CrossRef
- Ko, RJ (1998) Adulterants in Asian patent medicines. N Engl J Med 339: pp. 847 CrossRef
- Ang-Lee, MK, Moss, J, Yuan, CS (2001) Herbal medicines and perioperative care. JAMA 286: pp. 208-16 CrossRef
- Bent, S, Tiedt, TN, Odden, MC, Shlipak, MG (2003) The relative safety of ephedra compared with other herbal products. Ann Intern Med 138: pp. 468-71
- Shekelle, PG, Hardy, ML, Morton, SC (2003) Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 289: pp. 1537-45 CrossRef
- DHHS, FDA. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule. Fed Regist. 2004;69:6787–6854.
- Hoffman, BB, Taylor, P Neurotransmission. In: Hardman, JG, Limbird, LE eds. (2001) Goodman and Gilman’s The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, NY, pp. 115-53
- Haller, CA, Benowitz, NL, Jacob, P (2005) Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med 118: pp. 998-1003 CrossRef
- Adverse event reporting for dietary supplements: An inadequate safety valve. Office of the Inspector General, HHS., US:
- Bent, S, Padula, A, Neuhaus, J (2004) Safety and efficacy of citrus aurantium for weight loss. Am J Cardiol 94: pp. 1359-61 CrossRef
- Colker, C, Kalman, D, Torina, G, Perlis, T, Street, C (1999) Effects of Citrus aurantium extract, caffeine, and St. John’s Wort on body fat loss, lipid levels, and mood states in overweight healthy adults. Curr Ther Res 60: pp. 145-53 CrossRef
- Miracleburn with Hoodia and Advantra-Z! http://miracleburn.com/productinfo.htm. Accessed March 26, 2008.
- Morris, CA, Avorn, J (2003) Internet marketing of herbal products. JAMA 290: pp. 1505-9 CrossRef
- Blendon, RJ, DesRoches, CM, Benson, JM, Brodie, M, Altman, DE (2001) Americans’ views on the use and regulation of dietary supplements. Arch Intern Med 161: pp. 805-10 CrossRef
- Eisenberg, DM, Davis, RB, Ettner, SL (1998) Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA 280: pp. 1569-75 CrossRef
- Lewis, JD, Strom, BL (2002) Balancing safety of dietary supplements with the free market. Ann Intern Med 136: pp. 616-8
- Marcus, DM, Grollman, AP (2002) Botanical medicines—the need for new regulations. N Engl J Med 347: pp. 2073-6 CrossRef
- Jacobs, BP, Bent, S, Tice, JA, Blackwell, T, Cummings, SR (2005) An internet-based randomized, placebo-controlled trial of kava and valerian for anxiety and insomnia. Medicine (Baltimore) 84: pp. 197-207 CrossRef
- Fugh-Berman, A (2003) The 5-Minute Herb & Dietary Supplement Consult. Lippincott Williams & Wilkins, Philadelphia, PA
- Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation
Journal of General Internal Medicine
Volume 23, Issue 6 , pp 854-859
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- herbal medicine
- Industry Sectors
- Stephen Bent (1) (2) (3) (4)
- Author Affiliations
- 1. Osher Center for Integrative Medicine, University of California, San Francisco, CA, USA
- 2. Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA
- 3. Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
- 4. San Francisco VAMC, San Francisco, CA, USA